According to Bloomberg, demand was nearly seven times the available allocation, leaving most institutional investors without shares.
IPO Specifications
| Metric | Value |
| Ticker | ANT |
| Exchange | Nasdaq |
| IPO price | $83 |
| Shares offered | 980 million |
| Capital raised | $81.34 billion |
| Valuation | ~$1.5 trillion |
| Additional private placement | $26 billion |
| Expected trading start | 10:00 AM ET |
| Lead underwriters | Goldman Sachs, Morgan Stanley |
IPO vs. Previous Valuation
| Metric | Previous | IPO |
| Valuation | $965B | ~$1.5T |
| Share price | $70–$78 indicated range | $83 |
| Shares offered | 825M | 980M |
| Offering size | $57.75B–$64.35B | $81.34B |
The IPO valuation is approximately 55% higher than Anthropic's previous private valuation. The final share price exceeded the initial range ceiling by 6.4%.
Financial Performance
| Metric | Value |
| 2024 revenue | $386M |
| 2025 revenue | $4.585B |
| H1 2026 revenue | $16.286B |
| H1 2026 net loss | ~$80B |
| Compute and lease commitments over the next 12 months | Over $70B |
Institutional Demand
Bloomberg reported that most institutional buyers received no allocation at the $83 offering price, despite the IPO expansion.
The key indicators for ANT's first trading session are its opening price relative to $83, trading volume, and whether institutional demand supports the valuation.
Artem Voloskovets
Artem Voloskovets